A megakaryoblast is a precursor cell to a promegakaryocyte, which in turn becomes a megakaryocyte during haematopoiesis. It is the beginning of the thrombocytic series.
Contents
1Development
2Structure
3References
4External links
Development
The megakaryoblast derives from a CFU-Meg colony unit of pluripotential hemopoietic stem cells. (Some sources use the term "CFU-Meg" to identify the CFU.[1]) The CFU-Meg derives from the CFU-GEMM (common myeloid progenitor).
Structure
These cells tend to range from 8μm to 30μm, owing to the variation in size between different megakaryoblasts.[2] The nucleus is three to five times the size of the cytoplasm, and is generally round or oval in shape. Several nucleoli are visible, while the chromatin varies from cell to cell, ranging from fine to heavy and dense. The cytoplasm is generally basophilic and stains blue. In smaller cells, it contains no granules, but larger megakaryoblasts may contain fine granules.[3]
References
^Ganong, William F.; McPhee, Stephen J.; Lingappa, Vishwanath R. (2005). Pathophysiology of Disease: An Introduction to Clinical Medicine (Lange). McGraw-Hill Medical. p. 107. ISBN 0-07-144159-X.
^McClatchey, Kenneth, ed. (2002). Clinical Laboratory Medicine. Lippincott Williams & Wilkins. p. 802. ISBN 0683307517.
^Anderson, Shauna (2013). Anderson's Atlas of Hematology. Lippincott Williams & Wilkins. p. 129. ISBN 1469826364.
External links
Photo
Photo
Photo
Life cycle
v
t
e
Myeloid physiology
Hematopoiesis
Myelopoiesis (CFU-GEMM)
CFU-GM
Granulopoiesis
Myeloblast
Promyelocyte
Myelocyte
Metamyelocyte
Band cell
Monocytopoiesis
Monoblast
Promonocyte
MEP
Thrombopoiesis
Megakaryoblast
Promegakaryocyte
Erythropoiesis
Proerythroblast
Normoblast
Reticulocyte
General
Extramedullary hematopoiesis
Hemostasis
Coagulation
Fibrinolysis
Clot retraction
Platelet adhesiveness
Other
Erythrocyte aggregation
Authority control
TH: H2.00.04.3.05002
This cell biology article is a stub. You can help Wikipedia by expanding it.
v
t
e
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
1. 原発性骨髄線維症における病態 pathogenetic mechanisms in primary myelofibrosis
English Journal
Ocimum flavone Orientin as a countermeasure for thrombocytopenia.
Yadav M1, Song F1, Huang J1, Chakravarti A1, Jacob NK2.
Scientific reports.Sci Rep.2018 Mar 22;8(1):5075. doi: 10.1038/s41598-018-23419-x.
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line-a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia